文献速递泌尿生殖US

经直肠超声检测局灶性病变在前列腺癌检出中的作用:与系统六针活检的比较

The Role of Transrectal Ultrasound for Finding Focal Lesions in Prostate Cancer Detection Compared to Systematic Sextant Biopsy.
PubMed 文献 · Acad Radiol · 2018-10-10

回顾性纳入2014年4月至2017年4月行经直肠超声引导前列腺活检的患者,分为系统六针活检组(n=400)、局灶性病变靶向活检组(n=496)和无局灶性病变组(n=222);阳性活检率按局灶性病变组、六针活检组、无局灶性病变组顺序降低;PSA≤10 ng/mL时局灶性病变组前列腺癌及Gleason评分≥7的检出率高于六针活检组。

要点

  • 经直肠超声检出局灶性病变后行靶向活检,阳性活检率高于未仔细评估局灶性病变的系统六针活检。
  • PSA≤10 ng/mL时,靶向活检组前列腺癌检出率高于系统六针活检组(P=0.008)。
  • PSA≤10 ng/mL时,靶向活检组Gleason评分≥7前列腺癌检出率高于系统六针活检组(P=0.007)。

核心结论

  • 与未仔细行经直肠超声检查的系统六针活检相比,经直肠超声寻找局灶性病变有助于提高前列腺癌阳性活检率和风险分层。

研究设计与样本

  • 回顾性研究,纳入2014年4月至2017年4月行经直肠超声引导前列腺活检的患者,分为系统六针活检组(n=400)、经直肠超声检出局灶性病变的靶向活检组(n=496)和无经直肠超声检出局灶性病变组(n=222)。

诊断标准与关键数值

  • 阳性活检率按局灶性病变组、系统六针活检组、无局灶性病变组顺序降低(原文未报告具体数值)。
  • PSA≤10 ng/mL时,局灶性病变组全部前列腺癌检出率高于系统六针活检组(P=0.008)。
  • PSA≤10 ng/mL时,局灶性病变组Gleason评分≥7的前列腺癌检出率高于系统六针活检组(P=0.007)。
  • PSA>10 ng/mL时,无局灶性病变组全部前列腺癌检出率低于系统六针活检组(P=0.007)。
  • PSA>10 ng/mL时,无局灶性病变组Gleason评分≥7的前列腺癌检出率低于系统六针活检组(P=0.003)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the difference in cancer detection rate between targeted biopsy of focal lesions detected on transrectal ultrasound (TRUS) and systematic sextant biopsy.

MATERIALS AND METHODS: This retrospective study included patients who underwent TRUS-guided prostate biopsy between April 2014 and April 2017 and classified them into three groups: (1) sextant biopsy group patients underwent systematic sextant biopsy without evaluation of focal lesions on TRUS (n = 400), (2) focal lesion group patients underwent targeted biopsy for TRUS-detected lesions (n = 496), and (3) nonfocal lesion group patients had no TRUS-detected focal lesions (n = 222). Positive biopsy rates were compared using Chi-square tests between biopsy groups in all patients and two subgroups divided by prostate-specific antigen (PSA) level of 10 ng/mL.

RESULTS: The positive biopsy rate decreased in the order of the focal lesion group, the sextant biopsy group, and the nonfocal lesion group. All prostate cancers and prostate cancers with a Gleason score ≥7 were detected more frequently among patients with PSA ≤10 ng/mL in the focal lesion group than in the sextant biopsy group ( p = 0.008 and 0.007, respectively) and less frequently among patients with PSA >10 ng/mL in the nonfocal lesion group than in the sextant biopsy group ( p = 0.007 and 0.003, respectively).

CONCLUSION: In conclusion, searching focal lesion by TRUS is useful for improving the positive biopsy rate and risk stratification of PCa compared to systematic sextant biopsy without careful TRUS examination.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Choi MH, Lee YJ, Jung SE, et al. The Role of Transrectal Ultrasound for Finding Focal Lesions in Prostate Cancer Detection Compared to Systematic Sextant Biopsy. Acad Radiol. 2018. PMID: 30316704. doi:10.1016/j.acra.2018.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。